Somerset Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 20-11-2024
- Paid Up Capital ₹ 15.70 Cr
as on 20-11-2024
- Company Age 34 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 30.00 Cr
as on 20-11-2024
- Satisfied Charges ₹ 58.06 Cr
as on 20-11-2024
- Revenue 26.09%
(FY 2023)
- Profit -200.62%
(FY 2023)
- Ebitda -34.56%
(FY 2023)
- Net Worth -43.86%
(FY 2023)
- Total Assets 54.17%
(FY 2023)
About Somerset Therapeutics
The Corporate was formerly known as Recon Pharma Pvt Ltd. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 15.70 Cr.
The company currently has active open charges totaling ₹30.00 Cr. The company has closed loans amounting to ₹58.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Somerset Therapeutics Private Limited India are Kamala Tejoram as COMPANY SECRETARY and Sudhakar Krupendra as Cfo. Kannilakshmaniyer Paranjyothi, Ramasamy Thirumoorti, and Karupannan Murali serve as directors at the Company.
- CIN/LLPIN
U85110KA1990PTC011166
- Company No.
011166
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 1990
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Somerset Therapeutics Private Limited offer?
Somerset Therapeutics Private Limited offers a wide range of products and services, including Pharmaceutical Medicine, Cashew Nuts (Kaju), Split Cashew Nut, Brain & Nervous System Drugs, Psychotherapeutic Agents, Printing Paper, JK Copier Paper, Healing Crystals, Crystal Stone, A4 Size Paper.
Who are the key members and board of directors at Somerset Therapeutics?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamala Tejoram  | Company Secretary | Current | |
| Sudhakar Krupendra | CFO | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kannilakshmaniyer Paranjyothi | Director | 06-Dec-2012 | Current |
| Ramasamy Thirumoorti | Director | 11-Jul-2013 | Current |
| Karupannan Murali | Whole-Time Director | 01-Feb-2013 | Current |
Financial Performance and Corporate Structure Insights of Somerset Therapeutics.
Somerset Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.09% increase. The company also saw a substantial fall in profitability, with a 200.62% decrease in profit. The company's net worth observed a substantial decline by a decrease of 43.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Somerset Therapeutics?
In 2023, Somerset Therapeutics had a promoter holding of 95.34% and a public holding of 4.66%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Yashaha Laboratories Private LimitedActive 33 years 1 monthKannilakshmaniyer Paranjyothi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 01 Feb 2024 | ₹30.00 Cr | Open |
State Bank Of India Creation Date: 23 Feb 2022 | ₹10.00 Cr | Satisfied |
State Bank Of India Creation Date: 20 Apr 2015 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Somerset Therapeutics?
Somerset Therapeutics has a workforce of 511 employees as of Nov 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Somerset Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Somerset Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
